Carcinogenicity Testing and the Evaluation of Regulatory Requirements for Pharmaceuticals

By Contrera J.F.   Jacobs A.C.   deGeorge J.J.  

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 2, 1997-04 ,pp. : 130-145

Academic Press

Access to resources Recommend Favorite

Evaluation of the Carcinogenic Potential of Pharmaceuticals: Opportunities Arising from the International Conference on Harmonisation

By Monro A.M.  

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 309-319

Adis International

Access to resources Recommend Favorite

The Utility of Two Rodent Species in Carcinogenic Risk Assessment of Pharmaceuticals in Europe

By van Oosterhout J.P.J.   van der Laan J.W.   de Waal E.J.   Olejniczak K.   Hilgenfeld M.   Schmidt V.   Bass R.  

Regulatory Toxicology and Pharmacology, Vol. 25, Iss. 1, 1997-02 ,pp. : 6-17

Academic Press

Access to resources Recommend Favorite

Implications of Arsenic Genotoxicity for Dose Response of Carcinogenic Effects

By Rudel R.   Slayton T.M.   Beck B.D.  

Regulatory Toxicology and Pharmacology, Vol. 23, Iss. 2, 1996-04 ,pp. : 87-105

Academic Press

Access to resources Recommend Favorite

Dose-dependent modulation of systemic lipid peroxidation and activity of anti-oxidant enzymes by vitamin E in the rat

By Hajiani Maliheh   Golestani Abolfazl   Shariftabrizi Ahmad   Rastegar Roghieh   Payabvash Seyedmehdi   Hassanzadeh Salmasi Amirali   Reza Dehpour Ahmad   Pasalar Parvin  

Redox Report, Vol. 13, Iss. 2, 2008-04 ,pp. : 60-66

Maney Publishing

Access to resources Recommend Favorite